Epidemiological assessment of vaccine efficacy

Veterinary World

Volumn 2, Issue 3, 2009, Pages 118-122

  Asokan, G V ^a  

^a Inst of Vet Preventive Medicine   (India)

Author keywords

Epidemiology; Vaccine efficacy

Indexed keywords

EID: 79960368869     PISSN: 09728988     EISSN: 22310916     Source Type: Journal    
DOI: 10.5455/vetworld.2009.118-122     Document Type: Article

References (27)

1. Andersom RM. (1994): The croonian lecture. Populations, infectious disease and immunity: a very nonlinear world. Philosophical transactions of the Royal Society of London. Series B: Biology Sciences 346: 457-505.
2. Black S, Shinefield H and Ray P. (1997): Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one to two year old children: an analysis of vaccine safety data link (VSD) project. The Paediatric infectious disease journal 16: 500-03.
3. Dagan R, Eskola J and Leclerc C. (1998): Reduced response to multiple vaccines sharing common protective epitopes that are administered simultaneously to infants. Infection and immunity 66: 2093-98.
4. Erdman DD, Heath JL, Watson JC, Markowitz LE, Belini WJ. (1993): Immunoglobin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. Journal of Medical Virology 41: 44-48.
5. Farrington CP, Nash J and MillerE. (1996): Case series analysis of adverse reactions to vaccines: a comparative evaluation. American journal of epidemiology 143: 1165-73.
6. Gebauer F, De La Torre JC, Gomes I. (1988): Rapid selection of genetic antigenic variants of foot and mouth disease virus during persistence in cattle. Journal of virology 62: 2041-2049.
7. Gupta S, Swinton J and Anderson RM. (1994): Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria. Proceedings of the Royal Society of London B Biological Sciences 256: 231-8.
8. Halloran ME, Struchiner CJ. (1995): Causal inference for infectious diseases. Epidemiology 89: 115-18.
9. Halloran ME, Struchiner CJ and Longini IM Jr. (1997): Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American journal of epidemiology 146: 789-803.
10. Halloran ME, Anderson RM, Azevedo-neto, Bellini WJ, Branch O, Burke MA, Compaus R, Day K. (1998): Population biology, evolution and immunology of vaccination programs. The American journal of Medical Sciences 315 (5): 76-86.
11. Halloran ME, Ira Longini M and Struchiner CJ. (1999): Design and interpretation of vaccine field studies. Epidemiologic reviews 21(1): 73-88.
12. Harry guess A. (1999): Combination vaccines: issues in evaluation of effectiveness and safety. Epidemiologic reviews 21(1): 89-95.
13. Hunter RL and Lol AA. (1994): Copolymer adjutants in malaria vaccine development. The American journal of tropical medicine and hygiene 50(suppl-4): 52-58.
14. Insel RA. 1995. Potential alterations in immunogenecity by combining or simultaneously administering vaccine components. Annals of the New York Academy of Sciences 754: 35-47.
15. Leissel Talley and Peter Salama. (2003): Assessing field efficacy for measles in famine-affected rural Ethiopia. The American journal of tropical medicine and hygiene 68(5): 545-46
16. Lipstitch M. (1997): Vaccination against colonizing bacteria with multiple serotypes. Proceedings of the National Academy of Sciences of the United States of America 94: 6571-76.
17. Malfait P, Jataon IM and Jollet MC. (1994): Measles epidemic in the urban community of Niamey: transmission patterns, vaccine efficacy and immunization strategies, Niger, 1990 to 1991. The Paediatric infectious disease journal 13: 38-45.
18. McLean AR and Blower SM. (1993): Imperfect vaccines and herd immunity to HIV. Proceedings Transactions of Royal Society of London. Series: B Biology Sciences 253: 9-13.
19. Noah ND. (1980): Vaccination today. British Journal of Hospital Medicine 24: 533-36.
20. Norman begg and Elizabeth miller. (1990): Role of epidemiology in vaccine policy. Vaccine 8: 180-89.
21. Nowak MA, May RM and Phillips RE. (1995): Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375: 606-07.
22. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ and Sirotkin B. (1985): Field evaluation of vaccine efficacy. Bulletin of the World Health Organization 63: 1055-1068.
23. Patrick olin. (1989): Comparing the efficacies of pertusis vaccine. The Lancet 1: 95-96.
24. Peter Beverly. (2001): Vaccination. Ivan Roitt, Jonathan brostoff and David male. Immunology 6 th edn, pp 277-87. Mosby Edinburgh.
25. Pinner R W, Onyango F and Perkins BA. (1992): Epidemic meningococcal disease in Nairobi; Kenya 1989. The Kenya/centers for disease control (CDC) meningitis study group. The Journal of infectious diseases 166: 359-64.
26. Plowright W and R D Ferris. (1959): Studies with rinderpest virus in tissue culture. I. Growth and cytopathogenicity. Journal of comparative pathology and therapeutics 69: 152-172.
27. Plowright W. (1962): The application of monolayer tissue culture techniques in rinderpest research. II. The use of attenuated culture virus as a vaccine for cattle. Bulletin office international des epizooties 57: 253-276.